Read more at The New York Times.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
Date: |
-
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.3 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.3 days ago -
NBC News - Top stories
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.3 days ago -
CNBC - Business
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.2 days ago -
The Hill - Politics
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially” ...3 days ago -
MarketWatch - Business
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.3 days ago -
CBS News - Top stories
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.3 days ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high3 days ago -
The Hill - Politics
Novo CEO to blame drug middlemen
Presented by Prevent Cancer Foundation — The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss drugs Ozempic and Wegovy. ...9 hours ago
More from The New York Times
-
The New York Times - Health
Drug Overdose Deaths Are Dropping. The Reasons Are Not Perfectly Clear.
The decrease across the country is a major breakthrough in efforts to reverse the effects of fentanyl. Researchers and health officials say there is no easy explanation for the trend.2 days ago -
The New York Times - Health
Widowed and Looking for Love, Like the Golden Bachelorette
“The Golden Bachelorette” offers a glimpse at how dating changes after losing the love of your life. This is what it’s really like.Yesterday -
The New York Times - Health
Was It Really a Hot Zone Summer?
From Covid to dengue, viral outbreaks seemed to be popping up all over. But maybe Americans are just more attuned to threats now.16 hours ago -
The New York Times - Health
Rethinking Addiction as a Chronic Brain Disease
Some researchers argue that the roles of social environment and personal choice have to be considered in order to make progress in treating people addicted to drugs.September 3 -
The New York Times - Health
What R.F.K. Jr.’s Alliance With Trump Could Mean for Public Health
Robert F. Kennedy Jr., who has long voiced doubts about vaccine safety, has hopes of influencing federal health policy. Could he finally get the chance?5 days ago - Donald Trump